Fact CheckerSign in

NCT05432739Recruiting

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Source: ClinicalTrials.gov · Last updated 15 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

NIMBLE is a prospective study for blood biomarker study of lung nodules alongside analysing data which has been collected routinely as part of patient care. The primary aim of NIMBLE is to assess whether artificial intelligence and machine learning based radiomics approaches can be used to distinguish between benign disease and malignancy in a new lung nodule after a previously treated cancer, and where malignant to differentiate between metastatic recurrence or a new primary lung cancer.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
20 Jun 2022
Start date
7 Apr 2021
Primary completion date
1 Jan 2026
Lead sponsor
Royal Marsden NHS Foundation Trust
Diseases
Lung cancer
NCT number
NCT05432739

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 7 Apr 2021 to the primary completion date, 1 Jan 2026
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Active or previous diagnosis of malignancy (within 5 years preceding baseline scan).
  • Clinician-suspected or confirmed active or recent COVID-19 infection (less than 4 weeks before CT scan or required blood sampling date).

Other illness

  • Active infection (including tuberculosis or fungal infection).

Other

  • Inability to give informed consent.

Who the study is looking for

  • Patients under active investigation or surveillance for incidental lung nodules
  • Age \> 18.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Barking Havering and Redbridge University Hospitals NHS Trust
Coordinator of this site? Confirm its status
GoodmayesUnited KingdomRecruiting
Calderdale and Huddersfield NHS Foundation Trust
Coordinator of this site? Confirm its status
HuddersfieldUnited KingdomRecruiting
Whittington Health NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
University College London Hospitals NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Princess Alexandra Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Royal Marsden Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Guy's and St Thomas' NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Northumbria NHS Foundation Trust
Coordinator of this site? Confirm its status
Newcastle upon TyneUnited KingdomRecruiting
Nottinghamshire Healthcare NHS Foundation Trust
Coordinator of this site? Confirm its status
NottinghamUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.